Clinical Trial

French Validation of the Recovery Assessment Scale (RAS-FR)

Study acronym: VAL-RAS-FR
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The VAL-RAS-FR study aims to cross-culturally adapt, validate, and develop derived versions of the Recovery Assessment Scale (RAS), an internationally used self-report measure of subjective recovery in mental health. The study will include 260 adult psychiatric patients receiving care at EPSM Metz-Jury in both inpatient and outpatient settings. Participants will complete the French version of the RAS (RAS-FR), the WHOQOL-BREF, and additional self-report questionnaires. A subgroup of participants will complete the RAS-FR again after one month to assess test-retest reliability. The study will also explore existential aspects of recovery through the development of the RAS-FR-EX (Existential Extension) and support the development of a shorter version, the RAS-FR-SF (Short Form), for clinical and research purposes.
Trial Details
NCT Number NCT07667686
Lead Sponsor Etablissement Public de Santé Mentale de Metz-Jury
Collaborators: Centre Hospitalier Régional Metz-Thionville, Groupement Interrégional de Recherche Clinique et d'Innovation
Conditions Mental Health, Psychiatric Disorders
Enrollment 260 participants
Start Date 2026-06
Primary Completion 2027-01 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-25